The post Fourteen Big Feminist Wins in 2025 appeared first on Ms. Magazine.

The post Ms. Magazine’s Top Feminists of 2025 appeared first on Ms. Magazine.

Yet despite the drug’s promise, its development has been repeatedly stymied by abortion opponents who fear wider availability would weaken their attempts to suppress abortion access. 

The result? Women are left in needless pain and subject to invasive and unnecessary surgical procedures like hysterectomies.

The post Sneak Peek: What’s in the Winter Issue of Ms.? Groundbreaking Reporting on Women’s Health and Power appeared first on Ms. Magazine.

For my final entry of the year, we thought it worthwhile to offer a snapshot—a year’s worth of reporting on the depth of damage this administration has wreaked on women’s health, with real-time Contrarian reporting noted.

The post A Very Bad Year for Women’s Health appeared first on Ms. Magazine.

The post The Most-Read Ms. Stories of 2025 appeared first on Ms. Magazine.

Without the extension, more and more ACA marketplace enrollees will drop their increasingly costly health insurance plans. This comes at a time when the ACA is more popular than ever—recent polls show that across the political spectrum, three quarters of voters support extending the tax credits.

Could the administration's latest attack on transgender young people be the administration’s way of deflecting attention from the disaster unfolding in real time for millions of families in need of healthcare?  

The post Congress Went on Recess. Americans Got Higher Healthcare Bills. appeared first on Ms. Magazine.

“Abortion bans don’t stop people from needing and pursuing essential abortion care,” said Alison Norris, M.D., Ph.D., professor at The Ohio State University’s College of Public Health and #WeCount co-chair.

Despite these increases, Ushma Upadhyay, professor and fellow #WeCount co-chair, warned that unwarranted attacks on telehealth abortion may restrict access in the future. “This care is under assault by abortion opponents’ relentless attacks on mifepristone and telehealth—even though medication abortion is backed by a 25-year track record of safety and gold-standard science, and research shows that telehealth abortion is just as safe and effective as in-person care.”  

The post Abortion Continues to Increase in 2025 as Telehealth Expands, Especially in States with Bans and Restrictions appeared first on Ms. Magazine.

Joined by Florida, Texas Attorney General Ken Paxton filed the case on Dec. 9 in federal court in Wichita Falls. The two states argued in a 120-page complaint that the FDA did not properly evaluate mifepristone’s safety and effectiveness when approving the drug in 2000 and its subsequent generic versions. They also challenged the agency’s moves that expanded access to the pills, including the ability to dispense them by mail.

Abortion access advocates have blasted the lawsuit.

“If they succeed in restricting access to mifepristone, abortion access will be devastated across the country, even in states where abortion remains legal,” Shellie Hayes-McMahon, executive director of Planned Parenthood Advocates of Texas. “This lawsuit is not about safety or healthcare; it is about control. And nothing short of full control over our bodies will satisfy them.”

The post Texas and Florida Sue FDA in New Bid to Block Abortion Pill Access appeared first on Ms. Magazine.

Given the pivotal role of these medications in preserving abortion access, antiabortion policymakers and advocates are resorting to increasingly unscientific, unconventional tactics to spread mis- and disinformation about medication abortion and about mifepristone, one of two drugs used in most medication abortions in the United States.

In a disturbing new strategy, antiabortion policymakers are attempting to weaponize environmental laws and regulations, citing false claims that medication abortion pollutes U.S. waterways and drinking water.

The post No, Abortion Pills Aren’t Polluting U.S. Waterways appeared first on Ms. Magazine.

“It’s a huge revolution of who actually gets to decide when, how and with the support of whom they can have an abortion and until when," said Women Help Women coexecutive director Kinga Jelinska. "It centers the needs of users rather than institutions or markets. The underlying notion is that abortion can be friendly, and abortion can be easy.” 

Self-managed abortion is disruptive. We were told that abortion is a difficult decision; that it has to be difficult to access, and that only doctors control it. Self-managed abortion subverts that," said Lucía Berro Pizzarossa, fellow coexecutive founder.

The post A Global Telehealth First: Women Help Women Begins Producing Abortion Pill Combipack appeared first on Ms. Magazine.